or
forgot password
  • cancer clinical trials in bethesda, MD

  • A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma
    Center for Cancer and Blood Disorders

    Trial Locations
    Center for Cancer and Blood Disorders
    National Capital Clinical Research Consortium
    Lymphoma, Follicular
    Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Thoracic Malignancy, Lung Cancer, Esophageal Cancer, Malignant Pleural Mesothelioma
    Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    AIDS-Related Primary Central Nervous System Lymphoma, HIV
    Bevacizumab for Recurrent Malignant Glioma
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Recurrent High-Grade Gliomas, Malignant Gliomas
    ZD6474 to Treat Advanced Brain Cancer in Patients
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Recurrent High-Grade Gliomas, Progressive Low-Grade Gliomas, Malignant Gliomas
    Diffusion Tensor MRI to Distinguish Brain Tumor Recurrence From Radiation Necrosis
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Glioma Tumor Recurrence, Radiation Necrosis, Primary Brain Tumor
    Enzastaurin Versus Lomustine in Glioblastoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bethesda, Maryland 20817
    Glioblastoma
    Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    High Grade Gliomas, Brain Tumors
    Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Stage I Adrenocortical Carcinoma, Stage II Adrenocortical Carcinoma, Stage III Adrenocortical Carcinoma, Stage IV Adrenocortical Carcinoma
    Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors
    Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
    Bethesda, Maryland 20892-1182
    Neurofibromatosis Type 1, Sarcoma
    Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Metastatic Melanoma, Renal Cell Cancer
    Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
    Suburban Hospital
    Bethesda, Maryland 20814
    Breast Cancer, Cancer Survivor, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Sexuality and Reproductive Issues, Spiritual Concerns
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Suburban Hospital
    Bethesda, Maryland 20814
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
    Center for Cancer and Blood Disorders at Suburban Hospital
    Bethesda, Maryland 20817
    Multiple Myeloma and Plasma Cell Neoplasm
    LMB-2 to Treat Hairy Cell Leukemia
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Positive Hairy Cell Leukemia, CD25-Expressing Hairy Cell Leukemia
    Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma
    Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
    Bethesda, Maryland 20892-1182
    Intraocular Melanoma, Melanoma (Skin), Metastatic Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    BAY 43-9006 Plus Cetuximab to Treat Colorectal Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Metastatic Colorectal Cancer, EGFR-Expressing Metastatic CRC
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Suburban Hospital
    Bethesda, Maryland 20814
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Untreated Childhood Medulloblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Early Marker and Etiologic Studies in the PLCO Trial
    National Cancer Institute (NCI), 9000 Rockville Pike
    Bethesda, Maryland 20892
    Cancer
    Exploratory Data Analysis for Disease Pedigrees and Cancer Genetics
    National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
    Bethesda, Maryland 20892
    Data Analysis, Cancer Genetics
    Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
    National Cancer Institute (NCI), 9000 Rockville Pike
    Bethesda, Maryland 20892
    Lymphoma, Leukemia, Multiple Myeloma, Lymphoid Malignancies
    A Prospective Study of Diet and Cancer in Members of the American Association of Retired Persons
    National Cancer Institute (NCI), 9000 Rockville Pike
    Bethesda, Maryland 20892
    Nutrition, Cancer
    Genetic Epidemiology of Lung Cancer
    National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
    Bethesda, Maryland 20892
    Lung Cancer
    New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Pneumocystis Pneumonia
    Retinoblastoma Biomarker Study
    National Cancer Institute (NCI), 9000 Rockville Pike
    Bethesda, Maryland 20892
    Retinoblastoma
    Alemtuzumab (Campath(Registered Trademark)) to Treat T-Large Granular Lymphocyte Leukemia
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Lymphoproliferative Disorders
    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Identification of Viruses Associated With Diseases of Unknown Cause
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Viral Diseases
    Diagnostic Performance of Screening Tests for Cushing's Syndrome
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Cushing's Syndrome
    Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Pulmonary Disease, Oropharyngeal Disease, Lymphangioleiomyomatosis, Pulmonary Fibrosis, Asthma, Sarcoidosis
    Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
    National Naval Medical Center
    Bethesda, Maryland 20889
    Leukemia, Myelodysplastic Syndromes
    Effect of AdhAQP1 on Salivary Flow in Patients Treated With Radiation for Head and Neck Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Parotid Salivary Dysfunction
    Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome
    Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Stage III Wilms Tumor, Stage IV Wilms Tumor
    Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma
    Center for Cancer and Blood Disorders
    Bethesda, Maryland 20817
    Melanoma
    Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer
    Center for Cancer and Blood Disorders
    Bethesda, Maryland 20817
    Ovarian Cancer
    Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Untreated Childhood Medulloblastoma, Untreated Childhood Pineoblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
    NIH - Warren Grant Magnuson Clinical Center
    Bethesda, Maryland 20892-1182
    Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Secondary Myelofibrosis, Small Intestine Cancer
    Role of p53 Gene in Metabolism Regulation in Patients With Li-Fraumeni Syndrome
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Li-Fraumeni Syndrome, Cardiovascular Capacity
    A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
    Site Reference ID/Investigator# 2613
    Bethesda, Maryland 20892
    Chronic Lymphoid Leukemia, Lymphoid Malignancies, Non-Hodgkin's Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Peripheral T-cell Lymphoma
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Cancer Risk in X-Ray Technologists: Second Survey
    National Cancer Institute (NCI), 9000 Rockville Pike
    Bethesda, Maryland 20892
    Neoplasm
    Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM)
    National Heart, Lung, and Blood Institute
    Bethesda, Maryland 20892
    Lymphangioleiomyomatosis
    A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma
    Centers for Cancer and Blood Disorders

    Trial Locations
    Centers for Cancer and Blood Disorders
    Center for Cancer Research National Cancer Institute
    Peripheral T-cell Lymphoma
    Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Peritoneal Cancer
    O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy
    Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office

    Trial Locations
    Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
    NCI - Neuro-Oncology Branch
    Brain and Central Nervous System Tumors
    Tumor-Infiltrating Lymphocytes in Treating Patients With Persistent or Recurrent B-Cell Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia or Multiple Myeloma After a Previous Donor Stem Cell Transplant
    Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
    Bethesda, Maryland 20892-1182
    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
    Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Prostate Cancer
    Esophageal Cancer in Northeastern Iran
    National Cancer Institute (NCI), 9000 Rockville Pike
    Bethesda, Maryland 20892
    Esophageal Cancer
    Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Vaccine
    A Study of Enzastaurin and Erlotinib in Patients With Solid Tumors and Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bethesda, Maryland 20817
    Non-Small Cell Lung Cancer
    High-dose Bevacizumab in Advanced Renal Carcinoma Patients
    Center for Cancer and Blood Disorders
    Bethesda, Maryland 20817
    Renal Cancer, Kidney Cancer
    Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease
    Warren Grant Megnuson Clinical Center - NCI Clinical Trials Referral Office
    Bethesda, Maryland 20892
    Leukemia
    Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
    National Naval Medical Center
    Bethesda, Maryland 20889
    Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific